Joanne Wuensch
Stock Analyst at Citigroup
(4.37)
# 375
Out of 4,479 analysts
279
Total ratings
64.08%
Success rate
10.8%
Average return
Main Sectors:
29 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IART Integra LifeSciences Holdings | Maintains: Neutral | $24 → $28 | $29.19 | -4.08% | 6 | May 22, 2024 | |
| ITGR Integer Holdings | Maintains: Neutral | $118 → $124 | $115.75 | +7.13% | 2 | May 22, 2024 | |
| GKOS Glaukos | Maintains: Buy | $120 → $130 | $118.98 | +9.26% | 17 | May 22, 2024 | |
| BSX Boston Scientific | Maintains: Buy | $85 → $87 | $76.55 | +13.65% | 12 | May 22, 2024 | |
| BAX Baxter International | Maintains: Neutral | $44 → $38 | $32.85 | +15.68% | 12 | May 22, 2024 | |
| TNDM Tandem Diabetes Care | Upgrades: Buy | $40 → $57 | $39.15 | +45.59% | 11 | May 22, 2024 | |
| NVRO Nevro | Downgrades: Sell | $14 → $9 | $8.35 | +7.78% | 11 | May 22, 2024 | |
| ESTA Establishment Labs Holdings | Downgrades: Neutral | $60 | $42.75 | +40.35% | 3 | May 22, 2024 | |
| EW Edwards Lifesciences | Upgrades: Buy | $98 → $105 | $91.23 | +15.09% | 16 | May 22, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Neutral | $134 → $140 | $106.27 | +31.74% | 19 | Apr 3, 2024 | |
| SYK Stryker | Maintains: Buy | $362 → $406 | $334.30 | +21.45% | 9 | Apr 3, 2024 | |
| ISRG Intuitive Surgical | Maintains: Buy | $428 → $462 | $438.81 | +5.28% | 12 | Apr 3, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $88 → $103 | $76.33 | +34.94% | 2 | Apr 3, 2024 | |
| DXCM DexCom | Maintains: Buy | $148 → $161 | $112.49 | +43.12% | 9 | Apr 3, 2024 | |
| COO The Cooper Companies | Maintains: Buy | $108 → $116 | $86.51 | +34.09% | 18 | Apr 3, 2024 | |
| ABT Abbott Laboratories | Maintains: Buy | $126 → $128 | $103.20 | +24.03% | 14 | Apr 3, 2024 | |
| LUNG Pulmonx | Maintains: Buy | $16 → $17 | $6.32 | +168.99% | 9 | Feb 23, 2024 | |
| IRTC iRhythm Technologies | Upgrades: Buy | $110 | $98.61 | +11.55% | 15 | Dec 11, 2023 | |
| SILK Silk Road Medical | Downgrades: Sell | $35 → $8 | $27.02 | -70.39% | 10 | Oct 11, 2023 | |
| HAE Haemonetics | Maintains: Neutral | $90 → $94 | $83.06 | +13.17% | 6 | Oct 2, 2023 | |
| PEN Penumbra | Maintains: Buy | $390 → $320 | $175.99 | +81.83% | 18 | Oct 2, 2023 | |
| SGHT Sight Sciences | Maintains: Neutral | $8 → $4 | $6.16 | -35.06% | 7 | Sep 15, 2023 | |
| PODD Insulet | Upgrades: Buy | $273 → $265 | $197.19 | +34.39% | 9 | Aug 21, 2023 | |
| BLCO Bausch + Lomb | Maintains: Buy | $22 → $23 | $14.66 | +56.89% | 2 | Jul 10, 2023 | |
| JNJ Johnson & Johnson | Reinstates: Buy | $185 | $146.03 | +26.69% | 9 | May 30, 2023 | |
| BDX Becton, Dickinson and Company | Upgrades: Neutral | $220 → $250 | $229.24 | +9.06% | 4 | Dec 12, 2022 | |
| MDT Medtronic | Downgrades: Neutral | $108 → $85 | $77.37 | +9.86% | 9 | Nov 23, 2022 | |
| ALC Alcon | Maintains: Neutral | $67 → $69 | $88.79 | -22.29% | 4 | Nov 17, 2022 | |
| RMD ResMed | Upgrades: Outperform | n/a | $189.35 | - | 4 | Dec 10, 2018 |
Integra LifeSciences Holdings
May 22, 2024
Maintains: Neutral
Price Target: $24 → $28
Current: $29.19
Upside: -4.08%
Integer Holdings
May 22, 2024
Maintains: Neutral
Price Target: $118 → $124
Current: $115.75
Upside: +7.13%
Glaukos
May 22, 2024
Maintains: Buy
Price Target: $120 → $130
Current: $118.98
Upside: +9.26%
Boston Scientific
May 22, 2024
Maintains: Buy
Price Target: $85 → $87
Current: $76.55
Upside: +13.65%
Baxter International
May 22, 2024
Maintains: Neutral
Price Target: $44 → $38
Current: $32.85
Upside: +15.68%
Tandem Diabetes Care
May 22, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $39.15
Upside: +45.59%
Nevro
May 22, 2024
Downgrades: Sell
Price Target: $14 → $9
Current: $8.35
Upside: +7.78%
Establishment Labs Holdings
May 22, 2024
Downgrades: Neutral
Price Target: $60
Current: $42.75
Upside: +40.35%
Edwards Lifesciences
May 22, 2024
Upgrades: Buy
Price Target: $98 → $105
Current: $91.23
Upside: +15.09%
Zimmer Biomet Holdings
Apr 3, 2024
Maintains: Neutral
Price Target: $134 → $140
Current: $106.27
Upside: +31.74%
Stryker
Apr 3, 2024
Maintains: Buy
Price Target: $362 → $406
Current: $334.30
Upside: +21.45%
Intuitive Surgical
Apr 3, 2024
Maintains: Buy
Price Target: $428 → $462
Current: $438.81
Upside: +5.28%
GE HealthCare Technologies
Apr 3, 2024
Maintains: Buy
Price Target: $88 → $103
Current: $76.33
Upside: +34.94%
DexCom
Apr 3, 2024
Maintains: Buy
Price Target: $148 → $161
Current: $112.49
Upside: +43.12%
The Cooper Companies
Apr 3, 2024
Maintains: Buy
Price Target: $108 → $116
Current: $86.51
Upside: +34.09%
Abbott Laboratories
Apr 3, 2024
Maintains: Buy
Price Target: $126 → $128
Current: $103.20
Upside: +24.03%
Pulmonx
Feb 23, 2024
Maintains: Buy
Price Target: $16 → $17
Current: $6.32
Upside: +168.99%
iRhythm Technologies
Dec 11, 2023
Upgrades: Buy
Price Target: $110
Current: $98.61
Upside: +11.55%
Silk Road Medical
Oct 11, 2023
Downgrades: Sell
Price Target: $35 → $8
Current: $27.02
Upside: -70.39%
Haemonetics
Oct 2, 2023
Maintains: Neutral
Price Target: $90 → $94
Current: $83.06
Upside: +13.17%
Penumbra
Oct 2, 2023
Maintains: Buy
Price Target: $390 → $320
Current: $175.99
Upside: +81.83%
Sight Sciences
Sep 15, 2023
Maintains: Neutral
Price Target: $8 → $4
Current: $6.16
Upside: -35.06%
Insulet
Aug 21, 2023
Upgrades: Buy
Price Target: $273 → $265
Current: $197.19
Upside: +34.39%
Bausch + Lomb
Jul 10, 2023
Maintains: Buy
Price Target: $22 → $23
Current: $14.66
Upside: +56.89%
Johnson & Johnson
May 30, 2023
Reinstates: Buy
Price Target: $185
Current: $146.03
Upside: +26.69%
Becton, Dickinson and Company
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $229.24
Upside: +9.06%
Medtronic
Nov 23, 2022
Downgrades: Neutral
Price Target: $108 → $85
Current: $77.37
Upside: +9.86%
Alcon
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $88.79
Upside: -22.29%
ResMed
Dec 10, 2018
Upgrades: Outperform
Price Target: n/a
Current: $189.35
Upside: -